There have been numerous potential IPF biomarkers identified for evaluating disease severity and prognosis, including KL6, SP-A/D, matrix metalloproteinases, and osteopontin [8, 9, 24]. This evidence concerns the gene SPP1 and idiopathic pulmonary fibrosis.